<!DOCTYPE html><html lang="en-gb" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.4.0 for Hugo" />
  

  
  









  




  
  
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    
      
      <link rel="preload" as="style" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap">
      <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media="print" onload="this.media='all'">
    
  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Gabriel Mateus Bernardo Harrington" />

  
  
  
    
  
  <meta name="description" content="Purpose - Autologous Chondrocyte Implantation (ACI) requires a cartilage harvest and a subsequent cell implantation. There is a need to move towards therapies which are less invasive for patients and more cost-effective for health service providers. Allogeneic cells are one potential solution, but in order to manufacture them, alternatives for the autologous serum currently used in ACI protocols must be sought. To future-proof this process, a move towards xeno-free and serum-free protocols is also needed. &lt;br&gt;&lt;br&gt; Methods and Materials - Chondroprogenitors were isolated from full depth human knee cartilage using selective adhesion to fibronectin and cryopreserved at passage 2-3 prior to use in these experiments. One ‘healthy’ cadaveric donor (a 22yo with no history of osteoarthritis/injury) and n=3 arthroplasty donors (mean 72yo) were included. Two xeno-free and serum-free GMP compliant culture media were tested for chondroprogenitors expanded on vitronectin (StemMacs MSC Expansion (media A; Miltenyi Biotech) and StemPro MSC Expansion (media B; Gibco)) cf. standard culture in DMEM/F12 with foetal bovine serum (FBS). Growth kinetics, immunoprofiling, gene expression analysis (RT-PCR) (n=4 donors) and chondrogenic analyses (n=2 donors) were performed for chondroprogenitors grown over passages 3 and 4. &lt;br&gt;&lt;br&gt; Results - Chondroprogenitor manufacture in xeno-free and serum-free media does not significantly impact on their growth kinetics (population doubling level), immunoprofile (CD90, 73, 105, 44, 49c, 151, 29, 19, 34, 45, 49b, 14, 49a, 39 and HLA-DR) and, crucially, chondrogenic potential (GAG/DNA content), compared to FBS supplemented cultures. When expressed relative to FBS cultures, SOX-9 was significantly higher in media A cf. media B at passage 3. No other differences were found between expression levels in media A cf. B for any of the other genes tested (COLII, ACAN, COLX and ALK-1). &lt;br&gt;&lt;br&gt; Conclusion - Our preliminary data suggests that xeno-free and serum-free media can be used to manufacture allogeneic chondroprogenitors without negatively altering their growth or phenotype." />

  
  <link rel="alternate" hreflang="en-gb" href="https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  
    
    <script src="/js/mathjax-config.js"></script>
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.f1ecf783c14edc00c9320c205831ad8e.css" media="print" onload="this.media='all'">

  
  
  
    
    
      <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/academicons@1.9.1/css/academicons.min.css" integrity="sha512-W0xM4mr6dEP9nREo7Z9z+9X70wytKvMGeDsj7ps2+xg5QPrEBXC8tAW1IFnzjR6eoJ90JmCnFzerQJTLzIEHjA==" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    
    
    
    
      
      
    
    
    

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/github.min.css" crossorigin="anonymous" title="hl-light" media="print" onload="this.media='all'">
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" media="print" onload="this.media='all'" disabled>
        
      
    

    
    
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js" integrity="" crossorigin="anonymous" async></script>
      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.246129d782c938a644fe2d653d8a976f.css" />

  




<script async src="https://www.googletagmanager.com/gtag/js?id=UA-171428188-2"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'UA-171428188-2', {});
  gtag('set', {'cookie_flags': 'SameSite=None;Secure'});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  

  

  




  
  
  

  

  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
    <meta property="twitter:site" content="@CellTherapyRJAH" />
    <meta property="twitter:creator" content="@CellTherapyRJAH" />
  
  <meta property="og:site_name" content="Oswestry Keele Orthopaedic Research group - OsKOR" />
  <meta property="og:url" content="https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/" />
  <meta property="og:title" content="Assessing Allogeneic Chondroprogenitor Manufacture in Xeno-free and Serum-free Media | Oswestry Keele Orthopaedic Research group - OsKOR" />
  <meta property="og:description" content="Purpose - Autologous Chondrocyte Implantation (ACI) requires a cartilage harvest and a subsequent cell implantation. There is a need to move towards therapies which are less invasive for patients and more cost-effective for health service providers. Allogeneic cells are one potential solution, but in order to manufacture them, alternatives for the autologous serum currently used in ACI protocols must be sought. To future-proof this process, a move towards xeno-free and serum-free protocols is also needed. &lt;br&gt;&lt;br&gt; Methods and Materials - Chondroprogenitors were isolated from full depth human knee cartilage using selective adhesion to fibronectin and cryopreserved at passage 2-3 prior to use in these experiments. One ‘healthy’ cadaveric donor (a 22yo with no history of osteoarthritis/injury) and n=3 arthroplasty donors (mean 72yo) were included. Two xeno-free and serum-free GMP compliant culture media were tested for chondroprogenitors expanded on vitronectin (StemMacs MSC Expansion (media A; Miltenyi Biotech) and StemPro MSC Expansion (media B; Gibco)) cf. standard culture in DMEM/F12 with foetal bovine serum (FBS). Growth kinetics, immunoprofiling, gene expression analysis (RT-PCR) (n=4 donors) and chondrogenic analyses (n=2 donors) were performed for chondroprogenitors grown over passages 3 and 4. &lt;br&gt;&lt;br&gt; Results - Chondroprogenitor manufacture in xeno-free and serum-free media does not significantly impact on their growth kinetics (population doubling level), immunoprofile (CD90, 73, 105, 44, 49c, 151, 29, 19, 34, 45, 49b, 14, 49a, 39 and HLA-DR) and, crucially, chondrogenic potential (GAG/DNA content), compared to FBS supplemented cultures. When expressed relative to FBS cultures, SOX-9 was significantly higher in media A cf. media B at passage 3. No other differences were found between expression levels in media A cf. B for any of the other genes tested (COLII, ACAN, COLX and ALK-1). &lt;br&gt;&lt;br&gt; Conclusion - Our preliminary data suggests that xeno-free and serum-free media can be used to manufacture allogeneic chondroprogenitors without negatively altering their growth or phenotype." /><meta property="og:image" content="https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_300x300_fit_lanczos_3.png" />
    <meta property="twitter:image" content="https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_300x300_fit_lanczos_3.png" /><meta property="og:locale" content="en-gb" />
  
    
      <meta
        property="article:published_time"
        content="2009-07-04T15:53:28&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2022-05-05T12:47:43&#43;01:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/"
  },
  "headline": "Assessing Allogeneic Chondroprogenitor Manufacture in Xeno-free and Serum-free Media",
  
  "datePublished": "2009-07-04T15:53:28Z",
  "dateModified": "2022-05-05T12:47:43+01:00",
  
  "author": {
    "@type": "Person",
    "name": "Charlotte Hulme"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Group name (placeholder)",
    "logo": {
      "@type": "ImageObject",
      "url": "https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_192x192_fit_lanczos_3.png"
    }
  },
  "description": "Purpose - Autologous Chondrocyte Implantation (ACI) requires a cartilage harvest and a subsequent cell implantation. There is a need to move towards therapies which are less invasive for patients and more cost-effective for health service providers. Allogeneic cells are one potential solution, but in order to manufacture them, alternatives for the autologous serum currently used in ACI protocols must be sought. To future-proof this process, a move towards xeno-free and serum-free protocols is also needed. \u003cbr\u003e\u003cbr\u003e Methods and Materials - Chondroprogenitors were isolated from full depth human knee cartilage using selective adhesion to fibronectin and cryopreserved at passage 2-3 prior to use in these experiments. One ‘healthy’ cadaveric donor (a 22yo with no history of osteoarthritis/injury) and n=3 arthroplasty donors (mean 72yo) were included. Two xeno-free and serum-free GMP compliant culture media were tested for chondroprogenitors expanded on vitronectin (StemMacs MSC Expansion (media A; Miltenyi Biotech) and StemPro MSC Expansion (media B; Gibco)) cf. standard culture in DMEM/F12 with foetal bovine serum (FBS). Growth kinetics, immunoprofiling, gene expression analysis (RT-PCR) (n=4 donors) and chondrogenic analyses (n=2 donors) were performed for chondroprogenitors grown over passages 3 and 4. \u003cbr\u003e\u003cbr\u003e Results - Chondroprogenitor manufacture in xeno-free and serum-free media does not significantly impact on their growth kinetics (population doubling level), immunoprofile (CD90, 73, 105, 44, 49c, 151, 29, 19, 34, 45, 49b, 14, 49a, 39 and HLA-DR) and, crucially, chondrogenic potential (GAG/DNA content), compared to FBS supplemented cultures. When expressed relative to FBS cultures, SOX-9 was significantly higher in media A cf. media B at passage 3. No other differences were found between expression levels in media A cf. B for any of the other genes tested (COLII, ACAN, COLX and ALK-1). \u003cbr\u003e\u003cbr\u003e Conclusion - Our preliminary data suggests that xeno-free and serum-free media can be used to manufacture allogeneic chondroprogenitors without negatively altering their growth or phenotype."
}
</script>

  

  

  

  





  <title>Assessing Allogeneic Chondroprogenitor Manufacture in Xeno-free and Serum-free Media | Oswestry Keele Orthopaedic Research group - OsKOR</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="29a77d131283fb2ae6a5255262f47439" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.7e85d6cfe81caeb57cc49452f9b55e03.js"></script>

  




  <div class="page-header">
    











  


<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/"><img src="/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_0x70_resize_lanczos_3.png" alt="Oswestry Keele Orthopaedic Research group - OsKOR"
            
            ></a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/"><img src="/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_0x70_resize_lanczos_3.png" alt="Oswestry Keele Orthopaedic Research group - OsKOR"
          
          ></a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-start" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#about"><span>Home</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/people/"><span>Team</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/projects/"><span>Projects</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link  active" href="/publication/"><span>Publications</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/equipment/"><span>Equipment</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/post/"><span>Posts</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/events/"><span>Events</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/vacancies/"><span>Vacancies</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        
          
        

        
        

        
        
        <li class="nav-item dropdown theme-dropdown">
          <a href="#" class="nav-link" data-toggle="dropdown" aria-haspopup="true" aria-label="Display preferences">
            <i class="fas fa-moon" aria-hidden="true"></i>
          </a>
          <div class="dropdown-menu">
            <a href="#" class="dropdown-item js-set-theme-light">
              <span>Light</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-dark">
              <span>Dark</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-auto">
              <span>Automatic</span>
            </a>
          </div>
        </li>
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Assessing Allogeneic Chondroprogenitor Manufacture in Xeno-free and Serum-free Media</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/charlotte-hulme/">Charlotte Hulme</a></span>, <span >
      <a href="/author/sophie-bailey/">Sophie Bailey</a></span>, <span >
      <a href="/author/timothy-hopkins/">Timothy Hopkins</a></span>, <span >
      <a href="/author/helen-mccarthy/">Helen McCarthy</a></span>, <span >
      <a href="/author/ilyas-khan/">Ilyas Khan</a></span>, <span >
      <a href="/author/martyn-snow/">Martyn Snow</a></span>, <span >
      <a href="/author/karina-wright/">Karina Wright</a></span>, <span >
      <a href="/author/sb-and-chh-joint-first-authors/">*SB and CHH joint first authors</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    April 2022
  </span>
  

  

  

  
  
  
  
  
  

  
  

</div>

    





  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Purpose - Autologous Chondrocyte Implantation (ACI) requires a cartilage harvest and a subsequent cell implantation. There is a need to move towards therapies which are less invasive for patients and more cost-effective for health service providers. Allogeneic cells are one potential solution, but in order to manufacture them, alternatives for the autologous serum currently used in ACI protocols must be sought. To future-proof this process, a move towards xeno-free and serum-free protocols is also needed. <br><br> Methods and Materials - Chondroprogenitors were isolated from full depth human knee cartilage using selective adhesion to fibronectin and cryopreserved at passage 2-3 prior to use in these experiments. One ‘healthy’ cadaveric donor (a 22yo with no history of osteoarthritis/injury) and n=3 arthroplasty donors (mean 72yo) were included. Two xeno-free and serum-free GMP compliant culture media were tested for chondroprogenitors expanded on vitronectin (StemMacs MSC Expansion (media A; Miltenyi Biotech) and StemPro MSC Expansion (media B; Gibco)) cf. standard culture in DMEM/F12 with foetal bovine serum (FBS). Growth kinetics, immunoprofiling, gene expression analysis (RT-PCR) (n=4 donors) and chondrogenic analyses (n=2 donors) were performed for chondroprogenitors grown over passages 3 and 4. <br><br> Results - Chondroprogenitor manufacture in xeno-free and serum-free media does not significantly impact on their growth kinetics (population doubling level), immunoprofile (CD90, 73, 105, 44, 49c, 151, 29, 19, 34, 45, 49b, 14, 49a, 39 and HLA-DR) and, crucially, chondrogenic potential (GAG/DNA content), compared to FBS supplemented cultures. When expressed relative to FBS cultures, SOX-9 was significantly higher in media A cf. media B at passage 3. No other differences were found between expression levels in media A cf. B for any of the other genes tested (COLII, ACAN, COLX and ALK-1). <br><br> Conclusion - Our preliminary data suggests that xeno-free and serum-free media can be used to manufacture allogeneic chondroprogenitors without negatively altering their growth or phenotype.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#1">
              Conference abstract
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    

    <div class="space-below"></div>

    <div class="article-style">


</div>

    








<div class="share-box">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/&amp;text=Assessing%20Allogeneic%20Chondroprogenitor%20Manufacture%20in%20Xeno-free%20and%20Serum-free%20Media" target="_blank" rel="noopener" class="share-btn-twitter" aria-label="twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/&amp;t=Assessing%20Allogeneic%20Chondroprogenitor%20Manufacture%20in%20Xeno-free%20and%20Serum-free%20Media" target="_blank" rel="noopener" class="share-btn-facebook" aria-label="facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Assessing%20Allogeneic%20Chondroprogenitor%20Manufacture%20in%20Xeno-free%20and%20Serum-free%20Media&amp;body=https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/" target="_blank" rel="noopener" class="share-btn-email" aria-label="envelope">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/&amp;title=Assessing%20Allogeneic%20Chondroprogenitor%20Manufacture%20in%20Xeno-free%20and%20Serum-free%20Media" target="_blank" rel="noopener" class="share-btn-linkedin" aria-label="linkedin-in">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="whatsapp://send?text=Assessing%20Allogeneic%20Chondroprogenitor%20Manufacture%20in%20Xeno-free%20and%20Serum-free%20Media%20https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/" target="_blank" rel="noopener" class="share-btn-whatsapp" aria-label="whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://oskor.netlify.app/publication/assessing-allogeneic-chondroprogenitor-manufacture-in-xeno-free-and-serum-free-media/&amp;title=Assessing%20Allogeneic%20Chondroprogenitor%20Manufacture%20in%20Xeno-free%20and%20Serum-free%20Media" target="_blank" rel="noopener" class="share-btn-weibo" aria-label="weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  










<div class="article-widget">
  
<div class="post-nav">
  
  
  
  <div class="post-nav-item">
    <div class="meta-nav">Next</div>
    <a href="/publication/a-novel-tissue-engineering-approach-for-meniscus-replacement-evaluated-utilising-an-ovine-explant-model/" rel="next">A novel Tissue Engineering Approach for Meniscus Replacement Evaluated Utilising an Ovine Explant Model</a>
  </div>
  
  
  
  <div class="post-nav-item">
    <div class="meta-nav">Previous</div>
    <a href="/publication/autologous-chondrocyte-implantation-in-osteochondral-defects-of-the-talus-two-to-fourteen-year-follow-up-study/" rel="prev">Autologous Chondrocyte Implantation in Osteochondral Defects of the Talus: Two to Fourteen Year Follow-up Study</a>
  </div>
  
</div>

</div>





  
  





  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  



  

  

  
  <p class="powered-by">
    © 2025
  </p>
  

  
  






  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      

    
    <script src="/js/vendor-bundle.min.0047d4febf356e7f0b988e541f50b065.js"></script>

    
    
    
      
      
        <script src="https://cdn.jsdelivr.net/gh/desandro/imagesloaded@v4.1.4/imagesloaded.pkgd.min.js" integrity="sha512-S5PZ9GxJZO16tT9r3WJp/Safn31eu8uWrzglMahDT4dsmgqWonRY9grk3j+3tfuPr9WJNsfooOR7Gi7HL5W2jw==" crossorigin="anonymous"></script>
        <script src="https://cdn.jsdelivr.net/gh/metafizzy/isotope@v3.0.6/dist/isotope.pkgd.min.js" integrity="sha512-Zq2BOxyhvnRFXu0+WE6ojpZLOU2jdnqbrM1hmVdGzyeCa1DgM3X5Q4A/Is9xA1IkbUeDd7755dNNI/PzSf2Pew==" crossorigin="anonymous"></script>
      

      
      

      
        <script src="https://cdn.jsdelivr.net/gh/mermaid-js/mermaid@v8.8.4/dist/mermaid.min.js" integrity="sha512-+TNmhaRJf3jyYHTpzEq/5I6b+aGyhzWb21mGdHAjxSGSYwxN9Grug3Y3B9qVxWfKKY8MscE/6mr9walWvFLFvQ==" crossorigin="anonymous" title="mermaid"></script>
      

      
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/highlight.min.js" integrity="sha512-Ypjm0o7jOxAd4hpdoppSEN0TQOC19UtPAqD+4s5AlXmUvbmmS/YMxYqAqarQYyxTnB6/rqip9qcxlNB/3U9Wdg==" crossorigin="anonymous"></script>
        
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/r.min.js" crossorigin="anonymous"></script>
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/python.min.js" crossorigin="anonymous"></script>
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/latex.min.js" crossorigin="anonymous"></script>
        
      

    

    
    
    

    
    

    
    
    

    
    

    
    
    
    

    
    

    

    
    
    
    <script id="page-data" type="application/json">{"use_headroom":true}</script>

    
    
      <script src="/js/wowchemy-headroom.6b73888494485d3b0874ca2ec83f614f.js" type="module"></script>
    
    
    
    
    
    
    
    
    <script src="/en/js/wowchemy.min.8d464630e57565cec18d704bd3ef621f.js"></script>

    






</body>
</html>
